Psilocybin for Opioid Use Disorder (OUD)

NCT06796062 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Psilocybin

Sponsor

NYU Langone Health

Collaborators

National Institute on Drug Abuse (NIDA)